STASIS - I, II AND III; SERATHAN - A, B; INTRIN - EA, SI CALCIUM CHLORIDE 0.02M; FIBRINOGEN CONTROL-NORMAL, LOW
May 2007
403d
Wortham Laboratories, Inc. has submitted 1 FDA 510(k) premarket notifications since 2007, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Plasma, Control, Normal . Use the specialty filter in the sidebar to narrow results.